Loxapine: a six-month evaluation in severely ill schizophrenic patients

MeSH terms

• Administration, Oral
• Adult
• Antiparkinson Agents / therapeutic use
• Basal Ganglia Diseases / drug therapy
• Chronic Disease
• Dibenzoxazepines / administration & dosage
• Dibenzoxazepines / adverse effects
• Dibenzoxazepines / therapeutic use*
• Female
• Humans
• Male
• Middle Aged
• Piperazines / administration & dosage
• Piperazines / therapeutic use
• Psychiatric Status Rating Scales
• Schizophrenia / drug therapy*
• Succinates / administration & dosage
• Succinates / therapeutic use
• Tachycardia / chemically induced
• Tranquilizing Agents / administration & dosage
• Tranquilizing Agents / therapeutic use*